ABINGDON HEALTH PLC Logo

ABINGDON HEALTH PLC

ABDX | IL

Overview

Corporate Details

ISIN(s):
GB00BLB79S77 (+2 more)
LEI:
213800XFI4WV3FBILO20
Country:
United Kingdom
Address:
YORK BIOTECH CAMPUS, YO41 1LZ YORK
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Abingdon Health PLC is a contract development and manufacturing organization (CDMO) specializing in lateral flow rapid tests. The company provides comprehensive, end-to-end services supporting clients from initial concept through to commercial success. Core offerings include assay development, scale-up, technical transfer, high-volume manufacturing, regulatory consultancy, and commercialization support. The company serves a diverse range of sectors, including clinical diagnostics, animal health, and plant health. In addition to its contract services, Abingdon Health also develops, manufactures, and distributes its own portfolio of branded lateral flow products to a global network of consumers, retailers, and distributors.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for ABINGDON HEALTH PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 19:01
Director's Dealing
Director/PDMR Shareholding
English 26.1 KB
2025-08-05 08:00
Earnings Release
Trading update
English 24.6 KB
2025-07-31 08:00
Regulatory News Service
c. US$2.5m companion diagnostic test contract win
English 19.8 KB
2025-06-04 08:00
Board/Management Information
Update re. strategic partnership with FOFH
English 17.7 KB
2025-06-02 08:00
Regulatory News Service
Avian flu (H5N1) lateral flow test
English 23.7 KB
2025-03-17 08:00
Report Publication Announcement
Notice of Results
English 15.1 KB
2025-03-17 08:00
Regulatory News Service
Salistick™ to be launched in Germany
English 20.1 KB
2025-01-27 08:00
Regulatory News Service
Funding award to develop test for malaria parasite
English 20.1 KB
2025-01-08 08:00
Regulatory News Service
CS (Lifesciences) Ltd contract win
English 16.0 KB
2024-12-19 08:00
Board/Management Information
Directorate Change
English 25.3 KB
2024-12-17 08:09
Regulatory News Service
Abingdon Analytical Laboratory opens at Doncaster
English 16.9 KB
2024-12-17 08:00
Regulatory News Service
Contract win: sexually transmitted disease tests
English 17.8 KB
2024-11-19 13:00
Post-Annual General Meeting Information
Result of AGM
English 15.0 KB
2024-11-19 08:00
Post-Annual General Meeting Information
AGM Statement
English 16.0 KB
2024-10-21 17:00
Pre-Annual General Meeting Information
Notice of AGM
English 16.0 KB

Automate Your Workflow. Get a real-time feed of all ABINGDON HEALTH PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ABINGDON HEALTH PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
AcuCort AB Logo
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
Sweden ACUC
Advicenne Logo
Develops and commercializes therapies for rare renal diseases for patients of all ages.
France ALDVI
AegirBio AB Logo
Makes saliva-based diagnostics accessible for at-home & pro health & drug monitoring.
Sweden AEGIR
Aelis Farma Logo
Developing novel CB1 receptor inhibitors for treating brain and CNS disorders.
France AELIS
AGRONOMICS LIMITED Logo Isle of Man ANIC
ALK-Abelló Logo
Develops allergy immunotherapy (AIT) and emergency treatments for severe allergies.
Denmark ALK
Alkaloid AD Logo
Manufacturing pharmaceuticals, cosmetics, and botanicals for consumer and healthcare markets.
North Macedonia ALK